MENU

OTLK Outlook Therapeutics Forecast, Technical & Fundamental Analysis

Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications... Show more

Industry: #Biotechnology
OTLK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
OTLK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a manufacturer of biosimilar versions of biopharmaceuticals

Industry Biotechnology

Industry
Biotechnology
Address
111 S. Wood Avenue
Phone
+1 609 619-3990
Employees
17
Web
https://www.outlooktherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DVLU38.940.28
+0.72%
First Trust Dorsey Wright Momentum & Value ETF (DVLU)
SMMD85.880.36
+0.42%
iShares Russell 2500 ETF (SMMD)
RPAR21.13N/A
N/A
RPAR Risk Parity ETF (RPAR)
XTRE47.83-0.07
-0.15%
BondBloxx Bloomberg Three Year Target Duration US Treasury ETF (XTRE)
XLBI22.43-0.47
-2.05%
State Street Materials Select Sector SPDR Premium Income ETF (XLBI)

OTLK and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with APVO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then APVO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OTLK
1D Price
Change %
OTLK100%
+0.26%
APVO - OTLK
45%
Loosely correlated
-3.30%
ICU - OTLK
36%
Loosely correlated
-4.82%
GNPX - OTLK
34%
Loosely correlated
-12.33%
CYTK - OTLK
33%
Loosely correlated
-0.44%
PDSB - OTLK
33%
Loosely correlated
-5.94%
More
Outlook Therapeutics (OTLK) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com